HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era, Am J Respir Crit Care Med. 1 févr, vol.183, issue.3, pp.388-95, 2011. ,
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel, JAMA. 25 juill, vol.308, issue.4, pp.387-402, 2012. ,
Pneumocystis jirovecii pneumonia in patients with or without AIDS, France, Emerging Infect Dis. sept, vol.20, issue.9, pp.1490-1497, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01118531
Pneumocystosis: a network survey in the Paris area 2003-2008, Eur J Clin Microbiol Infect Dis. mai, vol.30, issue.5, pp.673-678, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00818520
Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem, J Med Microbiol. juill, vol.61, pp.1009-1024, 2012. ,
Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients, J Infect Chemother. juill, vol.20, issue.7, pp.412-418, 2014. ,
A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group, N Engl J Med, vol.323, issue.21, pp.1451-1458, 1990. ,
La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial, N Engl J Med, vol.323, issue.21, pp.1444-50, 1990. ,
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, MMWR Recomm Rep. 10 avr, vol.58, pp.1-207, 2009. ,
Update on the diagnosis and treatment of Pneumocystis pneumonia ,
, Ther Adv Respir Dis. févr, vol.5, issue.1, pp.41-59, 2011.
Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virusinfected patients: retrospective study of 31 patients, Clin Infect Dis. sept, vol.29, issue.3, pp.670-672, 1999. ,
Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia, Chest. mai, vol.113, issue.5, pp.1215-1239, 1998. ,
Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients, Antimicrob Agents Chemother, vol.55, issue.10, 2011. ,
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients, J Antimicrob Chemother, vol.71, issue.9, pp.2386-96, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01405217
Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection, AJR Am J Roentgenol. juin, vol.198, issue.6, pp.555-561, 2012. ,
A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure, Am J Respir Crit Care Med. 11 juill, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02003305
Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics, J Clin Pharmacol, vol.43, issue.11, pp.1216-1243, 2003. ,
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial, JAMA, vol.314, issue.16, pp.1711-1720, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01943927
Serial evaluation of the SOFA score to predict outcome in critically ill patients, JAMA, vol.286, issue.14, pp.1754-1762, 2001. ,
The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med. juill, vol.22, issue.7, pp.707-717, 1996. ,
Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study, Crit Care Med. août, vol.45, issue.8, pp.1317-1341, 2017. ,
Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data, Crit Care Med. janv, vol.36, issue.1, pp.100-107, 2008. ,
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, Intensive Care Med. févr, vol.39, issue.2, pp.165-228, 2012. ,
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the, 4th European Conference on Infections in Leukemia, vol.98, pp.1826-1861, 2011. ,
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, vol.40, issue.5, pp.373-83, 1987. ,
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clin Infect Dis. 15 juin, vol.46, issue.12, pp.1813-1834, 2008. ,
,
, EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis, vol.50, pp.538-580, 2012.
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia, 2017. ,
, Clinical Practice Guidelines by the Infectious Diseases Society of America and the, Clin Infect Dis. 1 sept, vol.63, issue.5, pp.575-82, 2016.
Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies, J Infect Chemother. déc, vol.18, issue.6, pp.793-806, 2012. ,
« Crazy-paving » pattern at thin-section CT of the lungs: radiologic-pathologic overview, Radiographics. déc, vol.23, issue.6, pp.1509-1528, 2003. ,
Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response, J Antimicrob Chemother, vol.01, issue.4, pp.1266-1274, 2017. ,
Pneumocystis Pneumonia in Solid-Organ Transplant Recipients, J Fungi (Basel). 28 sept, vol.1, issue.3, pp.293-331, 2015. ,
Pneumocystis carinii pneumonia in patients without AIDS, Clin Infect Dis. nov, vol.17, issue.2, pp.416-422, 1993. ,
Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features, Chest. août, vol.128, issue.2, pp.573-582, 2005. ,
Early Corticosteroids for Pneumocystis Pneumonia in Adults Without HIV Are Not Associated With Better Outcome, Chest. sept, vol.154, issue.3, pp.636-680, 2018. ,
Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia, Respir Res. 28 août, vol.14, p.87, 2013. ,
A Systematic Review and MetaAnalysis of the Data Behind Current Recommendations for Corticosteroids in Non-HIV-Related PCP: Knowing When You Are on Shaky Foundations, Transplant Direct. mars, vol.3, issue.3, p.137, 2017. ,
The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia, Semin Respir Infect. mars, vol.18, issue.1, pp.40-47, 2003. ,
Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study, Clin Infect Dis, vol.35, issue.8, pp.929-963, 2002. ,
Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients. Comparative study with non-AIDS patients, Chest. juin, vol.95, issue.6, pp.1198-201, 1989. ,
Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection, Scand J Infect Dis. sept, vol.44, issue.9, pp.670-677, 2012. ,
Human herpes virus coinfection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia, Eur J Clin Microbiol Infect Dis. févr, vol.32, issue.2, pp.189-94, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00872789
Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia, Respir Res. 28 août, vol.14, p.87, 2013. ,
,
, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux
, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte
, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences
, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs
, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément
, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses
, que je sois déshonoré(e) et méprisé(e) si j'y manque